Loading clinical trials...
Loading clinical trials...
TNF-related Weak Inducer of Apoptosis (TWEAK), a New Biomarker Predicting Inflammatory Thrust in Multiple Sclerosis
Conditions
Interventions
Determination of the circulating serum concentration of cytoquine TWEAK
Locations
1
France
Assistance Publique Hopitaux de Marseille
Marseille, France
Start Date
September 1, 2019
Primary Completion Date
September 1, 2020
Completion Date
September 1, 2021
Last Updated
June 5, 2019
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions